BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21334267)

  • 1. [Malignant glucagonoma: an uncommon cause of new onset diabetes].
    Guerrero Vázquez R; Oliva Rodríguez R; Cuenca Cuenca JI; Sánchez Alberdi F; Navarro González E
    Endocrinol Nutr; 2011 Apr; 58(4):199-201. PubMed ID: 21334267
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.
    Lo CH; Ho CL; Shih YL
    QJM; 2014 Feb; 107(2):157-8. PubMed ID: 23389434
    [No Abstract]   [Full Text] [Related]  

  • 3. Images in clinical medicine. Necrolytic migratory erythema.
    McGevna L; Tavakkol Z
    N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
    Boujan N; Géraud C
    Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
    Bouin M; Aoust LD
    Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucogonoma syndrome].
    De Haas ER; Sanders CJ; Schermer FJ; Lips CJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1336-7. PubMed ID: 10454886
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual Vignette.
    Sathyakumar S; Cherian KE; Jebasingh F; Hepzhibah J; Kapoor N; Paul TV
    Endocr Pract; 2017 Jan; 23(1):116. PubMed ID: 27631840
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
    Oberkirchner U; Linder KE; Zadrozny L; Olivry T
    Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.
    Kimbara S; Fujiwara Y; Toyoda M; Chayahara N; Imamura Y; Kiyota N; Mukohara T; Fukunaga A; Oka M; Nishigori C; Minami H
    Clin J Gastroenterol; 2014 Jun; 7(3):255-9. PubMed ID: 26183746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic glucagonoma with pancreatic calcification.
    Gupta RA; Udwadia FE; Agrawal P; Doctor N
    Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
    Tseng HC; Liu CT; Ho JC; Lin SH
    Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
    Zhu WF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant glucagonoma of the pancreas diagnoses through anemia and diabetes mellitus.
    Koike N; Hatori T; Imaizumi T; Harada N; Fukuda A; Takasaki K; Iwamoto Y
    J Hepatobiliary Pancreat Surg; 2003; 10(1):101-5. PubMed ID: 12918465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.